NAU IB Capital

NAU IB Capital is a private equity and venture capital firm based in Seoul, South Korea, specializing in early-stage investments in innovative startups. The firm manages capital on behalf of institutional, governmental, and private investors, operating numerous distinct growth capital investment platforms that invest across various financial sectors. NAU IB Capital employs a dual investment strategy, focusing on value investing to minimize downside risk and growth investing for upside potential.

The firm's investment approach encompasses a wide range of industries, including technology, healthcare, consumer goods, industrial goods, energy, financial services, media, telecommunications, retail, transportation, real estate, education, agriculture, food and beverage, and pharmaceuticals. NAU IB Capital's investment stages range from early-stage to growth, buyout, turnaround, and distressed situations, reflecting its versatile approach to capital deployment.

With a track record of 70 investments and 24 funds raised, NAU IB Capital has demonstrated a commitment to fostering innovation and supporting the growth of emerging companies. The firm's notable exits include AUTOCRYPT, Oncocross, and PeopleBio, underscoring its ability to identify and nurture successful ventures. NAU IB Capital's philosophy centers on delivering value to its investors while contributing to the advancement of the South Korean economy through strategic investments in high-potential startups.